In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...
It was a mixed bag for the aerospace giant, however, as they successfully caught the first stage booster upon its return to Earth, but lost communications with the Starship as it broke up while ...
In terms of sheer excitement, Elon Musk's company didn't disappoint, underscoring its technical prowess by catching the first stage booster in the "chopstick" arms of its launch tower for a second ...
SpaceX caught the Starship rocket’s Super Heavy booster for a second time, after it launched the upper stage into space on Thursday during a seventh test flight of the system. Soon after the ...
Read more about our advertising policy. Known for its broad availability and fast speeds, Xfinity internet options have a variety of plans to fit any budget. Cheapest starting prices across all ISPs.
Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in record time and quickly generating blockbuster revenue from it.
Moderna has lowered 2025 revenue guidance after a tough 2024 coronavirus vaccination season. However, the company aims to launch 10 new products over the next few years -- and that could lead to ...
SpaceX was able to duplicate its prior feat of catching a booster that returned to Earth. But 8.5 minutes into flight, the Starship spacecraft itself was lost. “Starship experienced a rapid ...
Ratings for Moderna MRNA were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings ...